VMP 41947911000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Dapsone 50mg tablets
BNF code 0501100H0AAAFAF
Virtual Therapeutic Moiety Dapsone
Date identifier became valid 9 Jun 2023
Previous product identifier 324506000
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Dapsone
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 50.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Dapsone 50mg tablets (A A H Pharmaceuticals Ltd)
Dapsone 50mg tablets (Accord-UK Ltd)
Dapsone 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Dapsone 50mg tablets (Almus Pharmaceuticals Ltd)
Dapsone 50mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Dapsone 50mg tablets (Medihealth (Northern) Ltd)
Dapsone 50mg tablets (Milpharm Ltd)
Dapsone 50mg tablets (Morningside Healthcare Ltd)
Dapsone 50mg tablets (Rivopharm (UK) Ltd)
Dapsone 50mg tablets (Sigma Pharmaceuticals Plc)
Dapsone 50mg tablets (Tillomed Laboratories Ltd)
Virtual Medicinal Product Packs
Dapsone 50mg tablets 100 tablet
Dapsone 50mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_5.3.0_20240527000001, imported on 27th May 2024 at 05:27:36.

Feedback